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Abstract
Background: The treatment of homeless dual-diagnosis patients (i.e., those with severe mental illness and
substance-use disorder) is difficult and often fails. For patients in the Netherlands who had not responded to earlier
voluntary and compulsory treatment, a new treatment facility – Sustainable Residence (SuRe) – was developed to
offer long-term compulsory in-patient treatment.
Aim of the study: To study patterns of changes in clinical and functional outcomes during treatment at SuRe and
how these relate to eventual treatment outcome.
Methods: On the basis of the intensity of care needed after four years, three groups of patients were distinguished
(total n = 165): those discharged to a less restrictive and less supportive setting (n = 70, 42%), those still hospitalized
at SuRe at the end of the four-year study period (n = 69, 42%) and those referred to a more appropriate setting
(n = 26, 16%). Random coefficient analysis was used to examine differences between groups regarding changes in
clinical and functional outcomes during treatment. During treatment, outcomes were monitored using Routine
Outcome Assessment.
Results: All three groups made small but significant improvements on global psychosocial functioning, distress and
therapeutic alliance (effect sizes (ES) 0.11 to 0.16 per year). Patients who were discharged to a less restrictive setting
showed small to moderate improvement in risk to self and others, psychiatric symptoms, and skills for daily living
(ES 0.19–0.33 per year and 0.42–0.73 for their mean 2.2-year treatment period). Patients remaining at SuRe showed
a small increase in risk to self (ES 0.20 per year; 0.80 for their treatment period of four years or more). Oppositional
behaviour was consistently greater in referred patients than in the other groups (ES 0.74–0.75).
Conclusion: Long-term compulsory treatment appeared to have helped improve clinical and functional outcomes
in a substantial proportion (42%) of previously severely dysfunctional, treatment-resistant dual-diagnosis patients,
who could then be discharged to a less restrictive and less supportive environment. However, risk-to-self increased
in a similar proportion. A smaller number of patients (16%) showed marked oppositional behaviour and needed a
higher level of care and protection in another facility.
Keywords: Severely mentally ill (SMI), Dual diagnosis, Compulsory treatment, Treatment resistant, Routine outcome
assessment
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Background
Treatment resistance and disengagement from mental-
health services are major obstacles in the treatment of diffi-
cult-to-engage patients with a dual diagnosis (i.e., those
with Severe Mental Illness (SMI) and substance-use dis-
order). About 50% of these patients do not respond well to
integrated outpatient services [1], partly because they lack
stable, safe and supportive living arrangements. Many of
them are homeless or live in neighbourhoods that are af-
fected by drug abuse. Similarly, as outpatient services for
difficult-to-engage SMI patients vary widely between the
large European cities, and as the overall quality of these ser-
vices is poor [2], many patients live on the streets, where
they cause nuisance and lack mental health care. As a con-
sequence of untreated psychotic symptoms and addiction
problems, they are at risk of victimization, somatic illnesses
and imprisonment for violent behaviour [2].
There is evidence that long-term residential dual-diag-
nosis programmes can be effective for dual-diagnosis pa-
tients who have not responded to outpatient treatment
[3]. However, if these programmes are voluntary, their
attrition rate can be as high as 75% [1]. Long-term
compulsory treatment may be an alternative for patients
who need mental healthcare and are a risk to themselves
or others, but continuously drop out of voluntary
programmes.
Sustainable residence (SuRe): long-term compulsory
treatment
Sustainable Residence (SuRe) was developed in the
Netherlands as a purpose-built long-term compulsory
treatment facility. It is intended for homeless dual-diag-
nosis patients who are seen as treatment-resistant by the
existing services, as they have a long history of treatment
efforts (including multiple compulsory admissions)
which did not lead to lasting improvements. [4]. Due to
their worrisome physical and psychological state, the pa-
tients posed a lasting risk to themselves and/or others,
and usually caused serious public nuisance.
Establishing a new structure to provide long-term in-
voluntary care has been controversial from the start of
SuRe. Such provision is at odds with reforms in mental
health care and the United Nations Convention of the
Rights of Persons with Disabilities, which aim to reduce
coercion and to maximize patient autonomy, among
other things. A strong need was felt, however, to avert
the grave risk of self-destruction these patients run, and
to improve their quality of life. A treatment option such
as SuRe was therefore deemed necessary, as a last resort:
an ‘ultimum remedium’.
Located in the northern Netherlands, this new and
unique treatment facility involves the collaboration of a
mental health service and an addiction service. It opened
in 2007. Patients are referred on the basis of involuntary
admission by the municipal health services of three
major Dutch cities. They are admitted for as long as ne-
cessary on the basis of a court order. To obtain such
order, an independent psychiatrist makes an assessment
which is requested by the treatment provider. This as-
sessment is sent to the judge, who decides on an exten-
sion of the order every six or twelve months.
Patients in the Netherlands can be admitted involun-
tarily only if they have been diagnosed with a mental dis-
order that makes them an actual or potential danger to
themselves and/or others. Their involuntary admission is
permitted only if they are unwilling to be admitted vol-
untarily and if there is no other recourse. This legal con-
text applies to all mental health facilities in the
Netherlands. However, when SuRe was established, the
context of patients admitted to it was discussed with the
District Attorney, particularly with regard to their his-
tory of involuntary admissions to psychiatric hospitals,
their failure to improve during treatment, and their his-
tory of neglect and trauma. It was agreed that account of
this context would be taken by judges issuing new court
orders.
Although treatment at SuRe focuses on improving pa-
tients’ functioning and quality of life, the extent to which
functional recovery was possible was unclear when SuRe
opened.
Aim of the study
To investigate the relationship between clinical changes
during treatment and eventual treatment outcomes of
long-term involuntary in-patient treatment of previously
treatment-resistant dual-diagnosis patients.
Methods
Design and setting
This observational study included all patients hospital-
ized at SuRe between August 2009 and January 2015.
Patients’ clinical and functional outcomes were moni-
tored during their treatment at SuRe, over a maximum
period of four years after their admittance. We excluded
patients who were still in treatment at SuRe in January
2015 but had not yet been in treatment for four years.
There are four criteria for admission to SuRe: (1) dual
diagnosis (SMI and substance-use disorder); (2) a history
of homelessness; (3) failure of earlier treatment to
achieve lasting improvement, despite the use of appro-
priate means, including multiple compulsory admissions;
and (4) the imposition of a civil-law court order for in-
voluntary admission on the grounds of the risk of lasting
danger to self or others.
The main criterion for discharge from SuRe is a reduc-
tion in the risk to oneself and/or others.
Over a four-year period we used Routine Outcome As-
sessment (ROA) to monitor developments in patients’
Kranenburg et al. BMC Psychiatry          (2019) 19:270 Page 2 of 9
clinical and functional outcomes during their hospitalization
at SuRe. ROA was part of standard care; it consisted of peri-
odic ratings of patient functioning by the patient’s case man-
ager or by the treatment provider who had principal
responsibility for the patient’s treatment.
The study protocol was reviewed and approved by the
Dutch Medical Ethical Committee for the Mental Health
Services and judged to be in accordance with the Dutch
Medical Research Involving Human Subjects Act (Metc
no. NL30019.097.09).
Study groups
On the basis of treatment facility at the end of the four-
year study period, we distinguished three study groups
of patients post hoc.
The first group, the Discharged group, consisted of pa-
tients for whom treatment at SuRe had been successful.
These patients had been discharged to a less restrictive
and less supportive setting, as exemplified by the legal
basis for admittance to the facility and its policy with re-
spect to leave, autonomy and the support provided to
patients. The second group, the Continued Care group,
consisted of patients who were still hospitalized at SuRe
after a minimum of four years because their treatment
was not yet complete. The third group, the Referred
group, consisted of patients for whom treatment at SuRe
had been unsuccessful. They had to be referred to a
more restrictive setting (usually a closed forensic psychi-
atric treatment facility) or a more appropriate one (usu-
ally a facility for the mentally disabled).
Treatment
Treatment at SuRe is comprehensive and highly sup-
portive. It is delivered by multidisciplinary teams con-
sisting of a psychiatrist, psychologist, case managers,
residential supervisors and domestic workers. The case
managers are the principal treatment providers. They
are nurses or social workers with a Bachelor’s degree
who coordinate the patients’ treatment and have an
overview of their condition and treatment, and also of
the patients’ social networks.
Other disciplines are also available: a somatic doctor,
nurses, social workers, creative therapists, psychomotor
therapists, social juridical workers, activity supervisors
and a cultural anthropologist. All patients in SuRe’s ad-
mission ward have a room of their own. The same com-
plex also has a crisis unit and a small unit for long-term
intensive care. When they have stabilized, patients move
to their own house in a closed area that was designed ac-
cording to the principles of a ‘healing environment’. If
their condition worsens, they can be referred to the cri-
sis unit for a short period or to the unit for intensive
care for a longer period. SuRe has a maximum capacity
of 133 patients.
Assessment of patients’ clinical and functional outcomes
The patients had been admitted to SuRe on the basis of
a civil-law court order stating that a psychiatric disorder
had caused them to pose a risk to themselves or others.
Risk to oneself or others was assessed with the Risk
Assessment Checklist (RAC) [5], a Dutch rating scale
developed for psychiatrists to rate patients who have
been committed by court order to compulsory treatment
order under Dutch civil law. The RAC rates seven types
of risk on a five-point scale (from 0 ‘no risk’ to 4 ‘high
risk’). Four types of risk are classified as a ‘risk to one-
self’: (1) the risk of committing suicide or otherwise
harming oneself, (2) the risk of social deterioration, (3)
the risk of serious self-neglect and (4) the risk of invok-
ing aggression due to disruptive behaviour. Similarly,
three types of risk are classified as ‘risks to others’: (1)
the risk of killing or seriously harming someone, (2) the
risk of damaging the mental health of others, and (3) the
risk to the general safety of persons or goods. Separate
sum scores are calculated for the risk-to-self items and
the risk-to-others items, with higher scores indicating
greater risk. The RAC is rated by the provider who has
principal responsibility for the patient’s treatment.
In addition to the risk to oneself or others, the follow-
ing aspects of patient functioning were assessed: psychi-
atric and addiction symptoms; somatic, cognitive and
psychosocial functioning; skills for activities of daily liv-
ing; and the patient’s working relationship with treat-
ment providers. These aspects of patient functioning
were assessed using the following five instruments:
(1) The split version of the Global Assessment of
Functioning (GAF) [6] was used as an overall measure of
patient functioning. This instrument has separate scales
for Symptoms and Disability. Ratings are made on scales
ranging from 0 to 100, with a higher score indicating
better patient functioning. The GAF was filled out by
the treatment provider who had principal responsibility
for the treatment.
(2) Symptoms and psychosocial functioning were
assessed using the Health of the Nation Outcomes Scale
(HoNOS) [7]. The HoNOS is used to assess adult men-
tal-health patients’ behavioural problems (including ad-
diction), disabilities, psychiatric symptoms and social
behaviour over the last two weeks. It consists of twelve
observer-rated items, each using five points from 0 (no
problems) to 4 (severe/very severe problems). Four
subscale scores are calculated by summing item scores:
Behaviour (3 items, e.g., overactive or agitated behaviour,
problem drinking or drug-taking); Impairments (2 items,
e.g., cognitive problems); Symptoms (3 items, e.g.,
depressed mood and problems associated with hallucina-
tions and delusions); and Social (4 items, e.g., problems
with relationships, and problems with activities of daily
living). In addition, a total score is calculated by
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summing all items. Higher scores on all scales indicate
worse patient functioning. The HoNOS was rated by the
patient’s case manager on the basis of inputs from the
team that provided the patient’s daily care and residen-
tial supervision.
(3) Activities of daily living and disruptive behaviour
were assessed using the Forensic Inpatient Observation
Scale (FIOS) [8], which was developed to assess the func-
tioning of forensic patients. It is divided into six subscales,
one of which was omitted (i.e., Insight) because the items
refer to offences committed by forensic patients. The
remaining five scales are (1) Self-care (7 items, e.g., brush-
ing teeth, and cleaning their room/house); (2) Social be-
haviour (6 items, e.g., joining the group for activities, and
starting a conversation); (3) Oppositional behaviour (10
items, e.g., verbal aggression, and lying); (4) Verbal skills
(3 items, e.g., understanding others, and talking intelli-
gibly); and (5) Distress (5 items, e.g., feelings of hopeless-
ness, and wishing to be dead). Quantitative ratings were
made through 5-point Likert scales (1 = never to 5 = al-
ways) on the basis of patient behaviour over a three-week
period. Higher rates indicate worse patient functioning.
The FIOS was rated in combination with the HoNOS by
the case manager and the team of daily care providers.
(4) Cognitive aspects of patient functioning were
assessed using the Executive Observation Scale (EOS),
a translation of the observation list developed by Pol-
lens [9]. It consists of eight items covering cognitive
and behavioural aspects of executive functioning in
everyday tasks: i.e., awareness, planning, goal setting,
self-initiation, self-inhibition, self-monitoring, and
ability to change set and strategic behaviour. Each
item is rated on a Likert scale from 1 (= complete in-
ability) to 4 (= complete independence and ability). A
single sum score is calculated, with higher scores in-
dicating better cognitive functioning. The EOS was
rated by the case manager and the team of daily care
providers.
(5) Because patients at SuRe have a history of dis-
engagement from care, we added the Helping Alliance
Scale [10] in order to assess the quality of the thera-
peutic alliance between the patient and treatment
providers. The scale has two versions: a client version
and a therapist version. For this study we used the
therapist version (HAS-T), which captures the thera-
pist’s view of his or her therapeutic alliance with the
patient. It is a short 5-item scale covering basic ele-
ments of a therapeutic relationship, e.g., understand-
ing the patient, and feeling actively involved and able
to treat him/her. These items are rated on 10-point
scales. A sum score of the five items is calculated,
with a higher score indicating the therapist’s opinion
that the therapeutic relationship is better. The HAS-T
was rated by the case manager.
Once a year all the scales per patient were adminis-
tered together. The HoNOS and FIOS were rated twice
more per year.
Analysis
Our analyses focused on the differences between the
three groups with regard to changes in clinical and func-
tional outcomes over four years. First, to test group dif-
ferences regarding baseline characteristics (i.e., upon
admission to SuRe), we used Chi-square tests for cat-
egorical characteristics and analysis of variance for con-
tinuous characteristics.
Then, to examine differences between the study groups
with regard to patients’ clinical and functional outcomes
over the four-year period, we used random coefficient
analyses – a specific type of linear mixed models that
takes account of the dependency of repeated observations
obtained from the same individual over time and is there-
fore suitable for performing regression analyses with re-
peated-measures data. This method also includes subjects
regardless of the number and timing of assessments over
the study period. For each clinical or functional outcome
separately, we tested whether there is (1) a main effect of
time (i.e., a linear increase or decrease in patient outcome
for all study groups over the four-year study period); (2) a
time-independent main effect of group (i.e., a stable differ-
ence in patient outcome between the study groups); or (3)
an interaction between time and group (i.e., differences
between study groups in the linear development of patient
outcome over time). To determine the best-fitting random
coefficient model, the likelihood ratio test was used to
compare models with random coefficients for intercept
and/or slope per subject. All tests used a significance level
of α = .05. Effect sizes were standardized by dividing the
effect on a patient outcome measure (either the difference
between group means or the change in outcome per year)
by the overall standard deviation for that specific outcome
on the first assessments per person.
Results
Two hundred and twenty-nine patients were hospital-
ized at SuRe between August 2009 and January 2015.
Sixty-four of them (27.9%) were excluded from the
present study: fifty because they had not yet received
four years of treatment, seven because they died at SuRe
before the first four years had elapsed, five because they
absconded from SuRe within their first four years, and
two because they were imprisoned during their first four
years at SuRe for crimes they had committed before
their admission. With regard to the baseline characteris-
tics listed in Table 1, those excluded did not differ sig-
nificantly from those included.
The final study sample consisted of a hundred and
sixty-five patients, seventy of whom (42.4%) had been
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discharged to a less restrictive and supportive mental
health facility within four years of admission to SuRe
(the Discharged group); sixty-nine of whom (41.8%) were
still in treatment at SuRe at the end of the four-year
study period (the Continued Care group); and twenty-six
of whom (15.8%) had been referred to a more appropri-
ate or more restrictive facility during the four-year
period (the Referred group).
With regard to the types of care, Discharged patients
moved to one of the following: an open psychiatric ward,
supported housing, supported independent living, or in-
dependent living with treatment by Assertive Commu-
nity Treatment teams. Patients in the Referred group
were referred either to a more restrictive setting (i.e., a
closed psychiatric treatment facility or a forensic psychi-
atric treatment facility) or to a more appropriate setting
(i.e., a treatment facility for the mentally disabled).
Except for patients in the Continued Care group, who
by definition had stayed for four years or more, the
mean hospital stay at SuRe was 2.2 years (SD = 1.1) in
the Discharged group, and 0.9 (0.7) years in the Referred
group (T = 6.46, p < .01).
Table 1 shows the baseline characteristics of the three
study groups, which differed significantly at baseline
with regard to the patients’ ages and histories of living
with a partner. Those in the Referred group had a sig-
nificantly lower mean age than those in the Discharged
and Continued Care groups. And whereas more Dis-
charged patients than Continued Care patients had ever
lived with a partner, the difference with Referred pa-
tients did not reach significance, due probably to the
small number of patients in the Referred group.
Table 2 shows the differences between study groups
with regard to developments in patient functioning in
the period studied. Main effects for group and time were
tested, as were the interaction between group and time
(as indicated in the top row of the table).
Differences between the study groups with regard to
developments in patients’ functioning (i.e., an interaction be-
tween group and time, as tested in columns 4 and 5 of the
table) were found on the Symptoms subscale of the HoNOS,
on the Self-care and Verbal Skills subscales of the FIOS, on
the Symptoms and Disability scales of the GAF, and on the
Risk to Self and Risk to Others subscales of the RAC.
Table 1 Baseline characteristics of study groups of dual-diagnosis patients admitted to Sustainable Residence
Characteristic Total (N = 165) Group Aa (N = 70) Group Ba (N = 69) Group Ca (N = 26) Χ2/F p Group Differencesb
Gender (% male) 84,2 78.6 87.0 92.3 3.04 .23
Age (mean in years, sd) 39.2 (8.2) 40.4 (8.6) 40.0 (7.8) 33.8 (5.7) 7.29 <.01 C < A; C < B
Educationd (%)
low 50.9 54.3 50.7 42.3 1.69 0.82
intermediate 23,0 21.4 27.5 15.4
high 7.9 5.7 10.1 7.7
missing 18.2 18.6 11.6 34.6
Country of birth (%)
Netherlands 44.2 42.9 44.9 46.2 3.03 0.22
otherc 49.1 52.9 55.1 23.1
missing 6.7 4.3 0.0 30.8
Lived with a partner (%)
yes 30.9 40.0 26.1 19.2 7,77 0.02 A > B
missing 31.5 34.3 24.6 42.3
Diagnosis on Axis I (%)
psychotic disorder 90.9 87.1 95.7 88.0 3,57 0.20
substance abuse 93.9 92.9 95.7 92.0 3.35 0.19
Diagnosis on Axis II (%)
personality disorder 36.4 31.4 39.1 42.3 1.93 0.38
borderline intellectual functioning 15.8 15.7 14.5 19.2 1.13 0.55
missing 12.7 15.7 5.8 23.1
a Group A: Discharged group; Group B: Continued Care group; Group C: Referred group
b Differences between groups significant at .05 level
c Countries on the following continents: South America (22.4%), Africa (12.1%), North America (8.5%), Asia (3.6%),
Europe (1.8%), Oceania (0.6%)
d Low: elementary school or less; intermediate: low-level/intermediate level secondary school; high: high level secondary
school, intermediate vocational or higher education
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On all these scales, the Discharged group (i.e., the pa-
tients discharged to less intensive care (group A in
Table 2)) showed improvements in functioning between
yearly assessments. In columns 10 to 13 of the table, these
developments over time are shown and tested for the
study group (or combination of groups) indicated in col-
umn 9; in the last column of the table they are compared
between groups. Based on the standard deviation (shown
below in brackets), the effect sizes of these improvements
per year were as follows: 0.24 per year for HoNOS-Symp-
toms (SD = 2.73); 0.19 for FIOS-Self-care (5.87); 0.31 for
FIOS-Verbal skills (2.17); 0.33 for GAF-Symptoms (9.52);
0.33 for GAF-Disability (6.51); 0.27 for Risk to Self (0.56);
and 0.24 for Risk to Others (0.62). In contrast, patients in
the Continued Care group (i.e., patients who remained at
SuRe (group B in Table 2)), showed a decline in patient
functioning regarding Risk to Self, with an effect size of
0.20 per year. In combination with the above interaction
effects, differences between groups at admission to SuRe
(shown and tested in columns 6 and 7 of Table 2) were
found on HoNOS-Symptoms, GAF-Symptoms, and Risk
to Self. As indicated in column 8 of Table 2, the Contin-
ued Care group showed better patient functioning at ad-
mission than the Referred group (i.e., patients referred to
a more appropriate or more restrictive setting (group C in
Table 2)) on the HoNOS-Symptoms scale (effects size
1.00), and better functioning than the Discharged group
on the GAF-Symptoms scale (0.86), and better than both
the Discharged and Referred groups on Risk to Self (0.84
resp. 1.18).
Patient functioning improved equally in all study groups
(i.e., a main effect of time was found) on the HoNOS-So-
cial subscale (effect size 0.14 per year; SD = 3.00); on the
HoNOS-Total scale (0.11; 6.39); the FIOS - Distress sub-
scale (0.12; 2.97); and the HAS-T scale (0.16; 1.05).
Finally, differences in functioning between the groups
were stable over the entire study period (i.e., main effect
of group) on the HoNOS-Behaviour subscale, with the
Discharged group showing significantly better functioning
than the Continued Care group (effect size 0.30; 2.10); and
with both the Discharged and Continued Care groups
showing better functioning than the Referred group (effect
sizes 1.26 and 0.97, respectively). Similarly, on the FIOS-
Oppositional Behaviour subscale, the Discharged group
(0.74) and Continued Care group (0.75) showed better
functioning than the Referred group (SD = 6.32).
There was no effect of group, time or group-time
interaction on the HoNOS-Impairment subscale, the
FIOS-Social behaviour subscale, or the Executive Obser-
vation Scale.
Discussion
In this study we evaluated long-term compulsory in-pa-
tient treatment for difficult-to-engage dual-diagnosis
patients. When they were referred to SuRe, all patients
were considered to be treatment resistant. Until this
study, the effects of long-term compulsory treatment
were unknown.
Our first important finding is that marked improve-
ments in functioning were possible in this group. Due to
improvements in functioning, a substantial number of
patients (42%) could be discharged within four years and
referred to less restrictive and less supportive facilities.
Our results also revealed meaningful differences in pa-
tient functioning and in improvements in functioning
between patients who were discharged, those in contin-
ued care, and those who were referred to another treat-
ment setting during treatment at SuRe.
Patients who were discharged to a less restrictive and
supportive setting (such as supported housing) showed
not only a decrease in risk to themselves and others, but
also improvements in psychiatric symptoms, self-care
behaviour, verbal skills and disability, with effect-sizes
ranging from 0.19–0.33 per year. Although these effects
may seem small, it should be remembered that the mean
duration of treatment in this patient group was 2.2 years.
Over the entire treatment period, the size of these effects
was medium large (0.42–0.73). These improvements in
functioning may have been instrumental to these pa-
tients’ referral to regular mental healthcare facilities. The
Discharged group also showed better functioning on the
HoNOS-Behaviour subscale than the other groups, and
scored better on the FIOS-Oppositional Behaviour sub-
scale than the Referred group. These differences were
already present at admittance to SuRe, and remained
during treatment. These findings may be useful to clini-
cians not only in shaping their expectations of treatment
and attuning their treatment approach, but also in
selecting patients for SuRe.
Although patients who remained at SuRe had started
out with lower scores on psychiatric symptoms and risk
to themselves than patients in the two other groups,
their risk to themselves increased during treatment. The
size of this effect was 0.20 per year. While this may raise
questions about the effectiveness of the treatment for
these patients, suggesting that the treatment had an
iatrogenic effect, functional deterioration is often
integral to the natural course of chronic psychosis – a
deterioration that may have been exacerbated by the
combination with long-term substance abuse. Patients’
awareness of these effects in clinical surroundings might
also reduce their motivation for treatment, and increase
demoralization and risk to self. At the very least, these
findings signal that this essential aspect of patient func-
tioning should be carefully monitored. The reason for
this increase should also be investigated, as it may be
crucial to decisions on extending or not extending treat-
ment at SuRe.
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From admission on, patients who were later referred
to a more restrictive or more appropriate facility – in
most cases a forensic one – had shown substantially
more behavioural problems and oppositional behaviour
(effect size 0.74 to 0.75) than other patients during their
treatment at SuRe. This may be an important issue to
consider when selecting patients for Sure. In all cases,
seriously dangerous behaviour (such as gravely harming
a supervisor) was the reason for their referral to another
setting. As the principal treatment approach at SuRe is
highly supportive, the question is whether these patients
actually need a more structured treatment approach and
a more restrictive setting, inside SuRe or elsewhere.
Although no improvements on the related measures of
impairment and social behaviour could be established,
we did find improvements during treatment for all pa-
tients regarding therapeutic alliance as perceived by the
treatment provider, distress and psychosocial function-
ing. The fact that we found no improvements on execu-
tive functioning may indicate that cognitive problems
are lasting results not only of a psychotic disorder, but
also of a way of life characterized by self-neglect and
long-term substance abuse.
Unlike with long-term voluntary treatment, there was
hardly any dropout from this patient group, even though
patients were permitted to go on leave. Only five pa-
tients failed to return after leaving SuRe.
Limitations
Even though the development of patient functioning was
modelled in a linear fashion, progress during the treat-
ment period may not be a linear process. But as the
number of assessments gathered by ROA was limited for
some outcomes, we preferred – for reasons of parsimo-
niousness – the simplification of treatment progress that
linear modelling provided. Neither did we assess out-
comes at fixed intervals or equally frequently for each
patient. This was a consequence of the way routine out-
come assessment takes place in everyday practice. How-
ever, the method of analysis we chose can accommodate
these peculiarities of the data we gathered.
A second limitation is the absence of a control
group, which lay in the impossibility of finding a suit-
able patient group or location. From both scientific
and practical points of view, the most informative op-
tion seemed to be to compare subgroups that clearly
differed in terms of the success of their treatment or
of their ‘suitability for treatment at SuRe’. Inevitably,
however, a risk of circular reasoning was introduced
by comparing developments in patients’ functioning
between groups that were selected on the basis of
their treatment outcome, or, more precisely, of their
referral to other services. The advantage of our ap-
proach however, is that it identified the developments
in specific aspects of patient functioning that are re-
lated to – and may also be instrumental to – ultimate
treatment and referral outcomes.
Conclusions
The treatment at SuRe has been controversial from the
start: patients are admitted involuntarily to a treatment fa-
cility for a length of time that is at odds with the reforms
in mental healthcare. The coercive nature of the treatment
has received particular criticism. Nonetheless, a substan-
tial proportion of severely dysfunctional dual-diagnosis
patients (42%), all of whom had been considered to be
treatment resistant, improved during long-term compul-
sory treatment, and could be discharged to less restrictive
and supportive facilities such as supported housing. Given
these results, treatment at SuRe is an alternative that en-
ables patients who drop out of voluntary programmes to
avoid ultimate physical and social deterioration.
It would be of great clinical value if it were possible to
predict with some certainty whether or not a patient be-
longs to this group.
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